Muscle Abnormalities in Children With XLH
NCT05312086 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2022-04-05
Summary
XLH rickets is a rare disease with muscle weakness. Fat parameters such as IMAT and intraMAT could be increased in this disease. IMAT and intraMAT will be calculated on MRI for 11 XLH children versus 20 typically developing children. The investigator will compare the percentage of IMAT in the XLH group versus control group and the difference concerning the intraMAT between the two groups.
Conditions
- Muscle Weakness
- XLH
Interventions
- OTHER
-
MRI
Performing the muscle MRI requires the cooperation of the child in order to remain lying down and motionless throughout the duration of the MRI, about 45 minutes. Performing MRI does not require the injection of contrast products or radiopharmaceuticals.
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 5 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-04-15
- Primary Completion
- 2023-06-15
- Completion
- 2023-06-15
More Related Trials
-
Cardiac Outcome Measures in Children With Muscular Dystrophy
NCT01066455 ·Status: COMPLETED
-
Quality of Life in Women with X-linked Adrenoleukodystrophy
NCT04675749 ·Status: RECRUITING
-
FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)
NCT03489993 ·Status: COMPLETED
-
Quantification of Elastin Markers Synthesis in Williams-Beuren Syndrome and 7q11.23 Micro-duplication Syndrome
NCT04051086 ·Status: UNKNOWN ·Phase: NA
-
Cardiac Function and Morphology Evaluated by Magnetic Resonance Imaging in Growth Hormone Deficiency and Acromegaly
NCT00970463 ·Status: COMPLETED
-
End-organ Pathology in Childhood Essential Hypertension
NCT00005180 ·Status: COMPLETED
-
Cerebral Anatomy, Hemodynamics and Metabolism
NCT02919956 ·Status: COMPLETED
-
A Cohort of Maternal Vascular Malperfusion-related FGR (CoMVMFGR)
NCT06104748 ·Status: RECRUITING
-
Biomarkers in Pediatric Congenital Heart Disease and PAH
NCT04130243 ·Status: UNKNOWN
-
Relevant Outcome Measures for Creatine Transporter Deficiency Patient
NCT06018519 ·Status: RECRUITING ·Phase: NA
-
Measurement of Lung Area at Chest Radiography to Define the Prognosis in Newborns With CDH
NCT04396028 ·Status: UNKNOWN
-
Study of Skeletal Disorders
NCT05031507 ·Status: RECRUITING
-
Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia
NCT04980638 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment Study of Faciocraniosynostosis by Craniofacial Osteodistraction
NCT01022008 ·Status: COMPLETED ·Phase: NA
-
Pathophysiology of Dilated Cardiomyopathy
NCT02001961 ·Status: WITHDRAWN
-
Long-term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type
NCT02455531 ·Status: ACTIVE_NOT_RECRUITING
-
RCDP Natural History Study
NCT04031287 ·Status: UNKNOWN
-
Biomarker Study for Heart Failure in Children With Single Ventricle Physiology
NCT00571233 ·Status: COMPLETED
-
Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease
NCT01821287 ·Status: COMPLETED
-
Single Ventricle Outcome
NCT00308217 ·Status: COMPLETED
-
Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single Ventricle Physiology
NCT01273857 ·Status: COMPLETED ·Phase: PHASE1
-
Mathematical Modeling to Determine Basic Muscle Properties in the Failing Heart
NCT01778894 ·Status: TERMINATED
-
IUGR, Respiratory Muscle Function, and Exercise Capacity in Childhood
NCT03368755 ·Status: UNKNOWN ·Phase: NA
-
Maternal Hyperoxygenation in Fetal Left Heart Hypoplasia
NCT05334966 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome
NCT02398604 ·Status: TERMINATED ·Phase: PHASE1